Jinlong YUE, Partner (Paris, France)

• Deal flow management and external collaboration
• Research Engineer in MRI/Ultrasound imaging  with a primary focus on of development and clinical application of ultrasound and magnetic resonance elastography technology
• Bachelor degree from Harbin Institute of Technology, PhD degree from Paris Sud University

 Robert Narquizian, Venture Partner (Switzerland/US)

• Partner in Fontaine Capital, Venture partner in Cenponts 
• Medicinal chemist by formation, ＞20 years in the pharmaceutical & biotech industry
• Director of BD and Licensing of Roche,  Head of Asia Pacific Global External R&D of Lilly Shanghai
• EMBA in London Business School, PhD in University of Glasgow, Post-doc in Harvard University 

Sophie Baratte, Venture Partner (France)

• Partner in Fontaine Capital, Venture partner in Cenponts
• ＞20 years General Management roles in Blue chip companies and in Start-ups

• CEO of Citoxlab, Cellnovo, General Manager of IVD J&J France, Vice President North EU of Sorin Group 

• MBA in HEC, PhD in Université de Technologie de Compiègne, Executive education in Harvard

 Eric Cohen, Venture Partner (Paris, France)

• Venture partner in Cenponts and Agile Capital Markets
• ＞20 years valuation & financial management experience in the Life Sciences industry
• CFO of Teva Pharma France，Hybrigenics，Mauna Kea Technologies，and Acticor Biotech
• Master degree from Dauphine University-Paris，MBA degree from London Business School

 Eric Zherui WU, Executive Director (Shenzhen, China)

• Project evaluation and execution 
• Research Associate Professor at the Medical School of Shenzhen University, Postdoctoral researcher at the French National Institute for Health and Medical Research 
• Piloted projects funded by the National and provincial Science Foundation, published over twenty peer-reviewed articles with a primary focus on translational medicine 
• Master degree of Toxicology in University of Paris V，PhD degree of Physiology, Physiopathology and Therapeutics in University of Paris VI

Rebecca WOLF, Executive Director (Berlin, Germany)

• Project evaluation in German speaking countries
• Close collaboration with innovative medical companies, industry experts, and investment institutions within the German-speaking region, extensive experience in cross-border financing, mergers and acquisitions, and licensing transactions
• Bachelor degree in Chemistry from Tsinghua University, Master degree from Fordham University